TABLE 6.
Parameter (%) | Edema | Erythema | Diarrhea | Blood in stool | Anorectal bleeding | Adhesion |
---|---|---|---|---|---|---|
UT | 0 | 0 | 0 | 0 | 0 | 0 |
Vehicle | 100 * | 100 * | 100 * | 40 * | 100 * | 100 * |
Mino 10 mg/kg | 100 * | 0 # | 0 # | 0 # | 0 # | 40 *# |
Bud 0.5 µg/kg | 40 *# | 0 # | 0 # | 0 # | 0 # | 20 *# |
Mino + Bud 5 mg/kg | 0 #$ | 0 # | 0 # | 0 # | 0 # | 0 #$ |
Colitis severity was assessed in UT mice and mice treated with DSS for 4 days, followed by 3 days of daily i. p administration of methylprednisolone or vehicle (PBS) (without DSS treatment) (n = 4 per group). * denotes a significant difference from UT mice; # denotes a significant difference from DSS/vehicle-treated mice.